ISM 2012
Date
29 Jan 2012 - 01 Feb 2012
Location
Organizer
Koelnmesse GmbH
Website

Nutraceuticals
New clinical study backs NuAxon Bioscience’s BioTurm curcumin for high bioavailability
A new human clinical study confirms that NuAxon Bioscience’s BioTurm curcumin provides 60 times higher bioavailability than standard curcumin with 95% standardized curcuminoids paired with piperine. The formulation achieves...

Nutraceuticals
Cannabis-based treatment with CBD and THC blend may fight ovarian cancer
New research points to the potential of future cannabis-based therapeutics to fight ovarian cancer. Scientists studying the effects of two chemical marijuana compounds — (non-psychoactive) cannabidiol (CBD) and...

Nutraceuticals
Carbyne Equity Partners acquires Suanfarma’s SuanNutra, entering nutraceutical market
Carbyne Equity Partners has acquired Suanfarma’s nutraceutical ingredients business, marking the private equity firm’s entry into a new sector. The move enables Carbyne’s further R&D-driven business with...
Related multimedia
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement












